Research programme: serotonin 2C receptor agonists - Bristol-Myers Squibb

Drug Profile

Research programme: serotonin 2C receptor agonists - Bristol-Myers Squibb

Alternative Names: A 37215; IK 264; IX 065

Latest Information Update: 18 Jan 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Small molecules
  • Mechanism of Action Serotonin 2C receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Obesity

Most Recent Events

  • 05 Apr 2005 This programme is still in active development - (229th American Chemical Society National Meeting (229th-ACS-2005))
  • 22 Oct 2002 A preclinical study has been added to the Obesity pharmacodynamics section
  • 23 Apr 2001 Preclinical development for Obesity in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top